Insider Stock Trading History of Celgene Corp /de/


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Celgene Corp /de/ since year 2005. The trader's CIK number is 816284. At the time of this reporting, Celgene Corp /de/ is the 10% Owner of Crispr Therapeutics Ag . (stock ticker symbol CRSP). See this page for all insider trading activities at Crispr Therapeutics Ag .

Note that in the past CELGENE CORP /DE/ also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Celgene Corp /de/ since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-06 CRSP Crispr Therapeutics Ag Sale 79,327 18.89 1,498,487
2017-12-01 CRSP Crispr Therapeutics Ag Sale 87,991 19.10 1,680,628
2017-11-17 CRSP Crispr Therapeutics Ag Sale 51,282 18.44 945,640
2017-11-16 CRSP Crispr Therapeutics Ag Sale 105,000 18.39 1,930,950
2017-11-15 CRSP Crispr Therapeutics Ag Sale 15,000 17.67 265,050
2017-11-14 CRSP Crispr Therapeutics Ag Sale 14,907 17.19 256,251
2017-11-13 CRSP Crispr Therapeutics Ag Sale 65,093 17.76 1,156,051
2017-11-10 CRSP Crispr Therapeutics Ag Sale 10,000 17.28 172,800
2017-11-29 CRSP Crispr Therapeutics Ag Sale 4,263 19.25 82,062
2017-11-28 CRSP Crispr Therapeutics Ag Sale 5,080 19.22 97,637
2017-11-27 CRSP Crispr Therapeutics Ag Sale 27,990 19.75 552,802
2017-11-24 CRSP Crispr Therapeutics Ag Sale 26,010 20.00 520,200
2017-11-22 CRSP Crispr Therapeutics Ag Sale 256,000 19.76 5,058,560
2017-11-20 CRSP Crispr Therapeutics Ag Sale 158,718 19.02 3,018,816
2017-11-09 CRSP Crispr Therapeutics Ag Sale 20,000 17.08 341,599
2017-11-08 CRSP Crispr Therapeutics Ag Sale 16,875 18.06 304,762
2017-11-07 CRSP Crispr Therapeutics Ag Sale 23,000 18.54 426,420
2018-11-21 CRSP Crispr Therapeutics Ag Sale 80,000 19.25 1,540,000
2017-12-04 CRSP Crispr Therapeutics Ag Sale 30,485 19.47 593,542
2017-11-30 CRSP Crispr Therapeutics Ag Sale 12,666 19.04 241,160
2017-11-03 CRSP Crispr Therapeutics Ag Sale 22,759 19.10 434,696
2017-09-25 XLRN Acceleron Pharma Inc Buy 745,592 37.00 27,586,904
2017-04-24 AGIO Agios Pharmaceuticals Inc Buy 624,575 49.50 30,916,462
2017-04-24 AGIO Agios Pharmaceuticals Inc Buy 624,575 49.50 30,916,462
2017-04-24 AGIO Agios Pharmaceuticals Inc Buy 624,575 49.50 30,916,462
2017-02-27 ALQA Alliqua, Inc. Buy 4,000,000 .50 2,000,000
2017-02-01 JNCE Jounce Therapeutics, Inc. Buy 625,000 16.00 10,000,000
2016-10-24 CRSP Crispr Therapeutics Ag Buy 800,150 14.00 11,202,100
2016-01-11 XLRN Acceleron Pharma Inc Buy 800,000 40.00 32,000,000
2015-05-04 ALQA Alliqua, Inc. Buy 659,340 4.55 2,999,997
2014-07-08 GBIM Globeimmune Inc Buy 200,000 10.00 2,000,000
2014-05-05 XLRN Acceleron Pharma Inc Buy 1,100,000 42.86 47,146,000
2014-04-14 ALQA Alliqua, Inc. Buy 714,286 7.00 5,000,002
2014-02-10 EPZM Epizyme, Inc. Buy 340,000 29.25 9,945,000
2014-01-28 XLRN Acceleron Pharma Inc Buy 300,000 50.00 15,000,000
2013-09-24 XLRN Acceleron Pharma Inc Buy 666,667 15.00 10,000,005
2013-06-05 EPZM Epizyme, Inc. Buy 66,666 15.00 999,990

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Celgene Corp /de/ (10% Owner of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.